Table of Content

1 Study Coverage
1.1 Long-Acting Reversible Contraception(LARC) Product Introduction
1.2 Market by Type
1.2.1 Global Long-Acting Reversible Contraception(LARC) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intrauterine Devices (IUCs)
1.2.3 Subcutaneous Implant
1.3 Market by Application
1.3.1 Global Long-Acting Reversible Contraception(LARC) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Age 20~24 Years Old
1.3.3 Age 25-34 Years Old
1.3.4 Age 35~44 Years Old
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Long-Acting Reversible Contraception(LARC) Sales Estimates and Forecasts 2018-2029
2.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Region
2.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2024)
2.2.3 Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2024-2029)
2.2.4 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2018-2029)
2.3 Global Long-Acting Reversible Contraception(LARC) Sales Estimates and Forecasts 2018-2029
2.4 Global Long-Acting Reversible Contraception(LARC) Sales by Region
2.4.1 Global Long-Acting Reversible Contraception(LARC) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024)
2.4.3 Global Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029)
2.4.4 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Long-Acting Reversible Contraception(LARC) Sales by Manufacturers
3.1.1 Global Long-Acting Reversible Contraception(LARC) Sales by Manufacturers (2018-2024)
3.1.2 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Long-Acting Reversible Contraception(LARC) in 2022
3.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Manufacturers
3.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Manufacturers (2018-2024)
3.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Long-Acting Reversible Contraception(LARC) Revenue in 2022
3.3 Global Key Players of Long-Acting Reversible Contraception(LARC), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Long-Acting Reversible Contraception(LARC) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Long-Acting Reversible Contraception(LARC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Product Offered and Application
3.8 Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Long-Acting Reversible Contraception(LARC) Sales by Type
4.1.1 Global Long-Acting Reversible Contraception(LARC) Historical Sales by Type (2018-2024)
4.1.2 Global Long-Acting Reversible Contraception(LARC) Forecasted Sales by Type (2024-2029)
4.1.3 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
4.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Type
4.2.1 Global Long-Acting Reversible Contraception(LARC) Historical Revenue by Type (2018-2024)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
4.3 Global Long-Acting Reversible Contraception(LARC) Price by Type
4.3.1 Global Long-Acting Reversible Contraception(LARC) Price by Type (2018-2024)
4.3.2 Global Long-Acting Reversible Contraception(LARC) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Long-Acting Reversible Contraception(LARC) Sales by Application
5.1.1 Global Long-Acting Reversible Contraception(LARC) Historical Sales by Application (2018-2024)
5.1.2 Global Long-Acting Reversible Contraception(LARC) Forecasted Sales by Application (2024-2029)
5.1.3 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
5.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Application
5.2.1 Global Long-Acting Reversible Contraception(LARC) Historical Revenue by Application (2018-2024)
5.2.2 Global Long-Acting Reversible Contraception(LARC) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
5.3 Global Long-Acting Reversible Contraception(LARC) Price by Application
5.3.1 Global Long-Acting Reversible Contraception(LARC) Price by Application (2018-2024)
5.3.2 Global Long-Acting Reversible Contraception(LARC) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Long-Acting Reversible Contraception(LARC) Market Size by Type
6.1.1 US & Canada Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2029)
6.1.2 US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2029)
6.2 US & Canada Long-Acting Reversible Contraception(LARC) Market Size by Application
6.2.1 US & Canada Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2029)
6.2.2 US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2029)
6.3 US & Canada Long-Acting Reversible Contraception(LARC) Market Size by Country
6.3.1 US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2029)
6.3.3 US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Long-Acting Reversible Contraception(LARC) Market Size by Type
7.1.1 Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2029)
7.1.2 Europe Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2029)
7.2 Europe Long-Acting Reversible Contraception(LARC) Market Size by Application
7.2.1 Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2029)
7.2.2 Europe Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2029)
7.3 Europe Long-Acting Reversible Contraception(LARC) Market Size by Country
7.3.1 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2029)
7.3.3 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Long-Acting Reversible Contraception(LARC) Market Size
8.1.1 China Long-Acting Reversible Contraception(LARC) Sales (2018-2029)
8.1.2 China Long-Acting Reversible Contraception(LARC) Revenue (2018-2029)
8.2 China Long-Acting Reversible Contraception(LARC) Market Size by Application
8.2.1 China Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2029)
8.2.2 China Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Long-Acting Reversible Contraception(LARC) Market Size by Type
9.1.1 Asia Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2029)
9.1.2 Asia Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2029)
9.2 Asia Long-Acting Reversible Contraception(LARC) Market Size by Application
9.2.1 Asia Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2029)
9.2.2 Asia Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2029)
9.3 Asia Long-Acting Reversible Contraception(LARC) Sales by Region
9.3.1 Asia Long-Acting Reversible Contraception(LARC) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2029)
9.3.3 Asia Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Market Size by Type
10.1.1 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Market Size by Application
10.2.1 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Country
10.3.1 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Overview
11.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bayer Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Information
11.3.2 Teva Pharmaceutical Overview
11.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Pharmaceutical Recent Developments
11.4 Allergan
11.4.1 Allergan Company Information
11.4.2 Allergan Overview
11.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Allergan Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Allergan Recent Developments
11.5 HRA Pharma
11.5.1 HRA Pharma Company Information
11.5.2 HRA Pharma Overview
11.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 HRA Pharma Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HRA Pharma Recent Developments
11.6 Eurogine
11.6.1 Eurogine Company Information
11.6.2 Eurogine Overview
11.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Eurogine Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eurogine Recent Developments
11.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
11.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
11.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Overview
11.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Developments
11.8 Wuxi Tianyi Medical Equipment Co., Ltd.
11.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
11.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Overview
11.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Recent Developments
11.9 SMB Corporation
11.9.1 SMB Corporation Company Information
11.9.2 SMB Corporation Overview
11.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 SMB Corporation Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SMB Corporation Recent Developments
11.10 Shenyang Liren
11.10.1 Shenyang Liren Company Information
11.10.2 Shenyang Liren Overview
11.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shenyang Liren Recent Developments
11.11 Tianjin Hejie Medical Equipment Co., Ltd.
11.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Information
11.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Overview
11.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Recent Developments
11.12 Cooper Companies
11.12.1 Cooper Companies Company Information
11.12.2 Cooper Companies Overview
11.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Cooper Companies Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Cooper Companies Recent Developments
11.13 AbbVie Allergan
11.13.1 AbbVie Allergan Company Information
11.13.2 AbbVie Allergan Overview
11.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 AbbVie Allergan Recent Developments
11.14 Organon
11.14.1 Organon Company Information
11.14.2 Organon Overview
11.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Organon Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Organon Recent Developments
11.15 Shanghai Dahua Pharmaceutical
11.15.1 Shanghai Dahua Pharmaceutical Company Information
11.15.2 Shanghai Dahua Pharmaceutical Overview
11.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shanghai Dahua Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Long-Acting Reversible Contraception(LARC) Industry Chain Analysis
12.2 Long-Acting Reversible Contraception(LARC) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Long-Acting Reversible Contraception(LARC) Production Mode & Process
12.4 Long-Acting Reversible Contraception(LARC) Sales and Marketing
12.4.1 Long-Acting Reversible Contraception(LARC) Sales Channels
12.4.2 Long-Acting Reversible Contraception(LARC) Distributors
12.5 Long-Acting Reversible Contraception(LARC) Customers
13 Market Dynamics
13.1 Long-Acting Reversible Contraception(LARC) Industry Trends
13.2 Long-Acting Reversible Contraception(LARC) Market Drivers
13.3 Long-Acting Reversible Contraception(LARC) Market Challenges
13.4 Long-Acting Reversible Contraception(LARC) Market Restraints
14 Key Findings in The Global Long-Acting Reversible Contraception(LARC) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Long-Acting Reversible Contraception(LARC) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Intrauterine Devices (IUCs)
Table 3. Major Manufacturers of Subcutaneous Implant
Table 4. Global Long-Acting Reversible Contraception(LARC) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Long-Acting Reversible Contraception(LARC) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2018-2024)
Table 9. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2024-2029)
Table 10. Global Long-Acting Reversible Contraception(LARC) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024) & (K Units)
Table 12. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029) & (K Units)
Table 13. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2018-2024)
Table 14. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2024-2029)
Table 15. Global Long-Acting Reversible Contraception(LARC) Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Long-Acting Reversible Contraception(LARC) Sales Share by Manufacturers (2018-2024)
Table 17. Global Long-Acting Reversible Contraception(LARC) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Long-Acting Reversible Contraception(LARC), Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Long-Acting Reversible Contraception(LARC) Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Long-Acting Reversible Contraception(LARC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Long-Acting Reversible Contraception(LARC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Reversible Contraception(LARC) as of 2022)
Table 23. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Product Offered and Application
Table 25. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 28. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 29. Global Long-Acting Reversible Contraception(LARC) Sales Share by Type (2018-2024)
Table 30. Global Long-Acting Reversible Contraception(LARC) Sales Share by Type (2024-2029)
Table 31. Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Type (2018-2024)
Table 34. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Type (2024-2029)
Table 35. Long-Acting Reversible Contraception(LARC) Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Long-Acting Reversible Contraception(LARC) Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 38. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 39. Global Long-Acting Reversible Contraception(LARC) Sales Share by Application (2018-2024)
Table 40. Global Long-Acting Reversible Contraception(LARC) Sales Share by Application (2024-2029)
Table 41. Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Application (2018-2024)
Table 44. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Application (2024-2029)
Table 45. Long-Acting Reversible Contraception(LARC) Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Long-Acting Reversible Contraception(LARC) Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Long-Acting Reversible Contraception(LARC) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Long-Acting Reversible Contraception(LARC) Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 60. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 61. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 62. Europe Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Long-Acting Reversible Contraception(LARC) Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 65. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 66. Europe Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Long-Acting Reversible Contraception(LARC) Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Long-Acting Reversible Contraception(LARC) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 72. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 73. China Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 74. China Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 75. China Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Long-Acting Reversible Contraception(LARC) Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 78. China Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 79. China Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Long-Acting Reversible Contraception(LARC) Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 82. Asia Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 83. Asia Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Long-Acting Reversible Contraception(LARC) Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 86. Asia Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 87. Asia Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Long-Acting Reversible Contraception(LARC) Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Long-Acting Reversible Contraception(LARC) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Long-Acting Reversible Contraception(LARC) Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024) & (K Units)
Table 93. Asia Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 107. Bayer Company Information
Table 108. Bayer Description and Major Businesses
Table 109. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Teva Pharmaceutical Company Information
Table 118. Teva Pharmaceutical Description and Major Businesses
Table 119. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Pharmaceutical Recent Developments
Table 122. Allergan Company Information
Table 123. Allergan Description and Major Businesses
Table 124. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Allergan Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Allergan Recent Developments
Table 127. HRA Pharma Company Information
Table 128. HRA Pharma Description and Major Businesses
Table 129. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. HRA Pharma Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. HRA Pharma Recent Developments
Table 132. Eurogine Company Information
Table 133. Eurogine Description and Major Businesses
Table 134. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Eurogine Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eurogine Recent Developments
Table 137. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
Table 138. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Description and Major Businesses
Table 139. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Developments
Table 142. Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
Table 143. Wuxi Tianyi Medical Equipment Co., Ltd. Description and Major Businesses
Table 144. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Wuxi Tianyi Medical Equipment Co., Ltd. Recent Developments
Table 147. SMB Corporation Company Information
Table 148. SMB Corporation Description and Major Businesses
Table 149. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. SMB Corporation Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. SMB Corporation Recent Developments
Table 152. Shenyang Liren Company Information
Table 153. Shenyang Liren Description and Major Businesses
Table 154. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shenyang Liren Recent Developments
Table 157. Tianjin Hejie Medical Equipment Co., Ltd. Company Information
Table 158. Tianjin Hejie Medical Equipment Co., Ltd. Description and Major Businesses
Table 159. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Tianjin Hejie Medical Equipment Co., Ltd. Recent Developments
Table 162. Cooper Companies Company Information
Table 163. Cooper Companies Description and Major Businesses
Table 164. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Cooper Companies Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Cooper Companies Recent Developments
Table 167. AbbVie Allergan Company Information
Table 168. AbbVie Allergan Description and Major Businesses
Table 169. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. AbbVie Allergan Recent Developments
Table 172. Organon Company Information
Table 173. Organon Description and Major Businesses
Table 174. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Organon Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Organon Recent Developments
Table 177. Shanghai Dahua Pharmaceutical Company Information
Table 178. Shanghai Dahua Pharmaceutical Description and Major Businesses
Table 179. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Shanghai Dahua Pharmaceutical Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Long-Acting Reversible Contraception(LARC) Distributors List
Table 185. Long-Acting Reversible Contraception(LARC) Customers List
Table 186. Long-Acting Reversible Contraception(LARC) Market Trends
Table 187. Long-Acting Reversible Contraception(LARC) Market Drivers
Table 188. Long-Acting Reversible Contraception(LARC) Market Challenges
Table 189. Long-Acting Reversible Contraception(LARC) Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-Acting Reversible Contraception(LARC) Product Picture
Figure 2. Global Long-Acting Reversible Contraception(LARC) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Long-Acting Reversible Contraception(LARC) Market Share by Type in 2022 & 2029
Figure 4. Intrauterine Devices (IUCs) Product Picture
Figure 5. Subcutaneous Implant Product Picture
Figure 6. Global Long-Acting Reversible Contraception(LARC) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Long-Acting Reversible Contraception(LARC) Market Share by Application in 2022 & 2029
Figure 8. Age 20~24 Years Old
Figure 9. Age 25-34 Years Old
Figure 10. Age 35~44 Years Old
Figure 11. Other
Figure 12. Long-Acting Reversible Contraception(LARC) Report Years Considered
Figure 13. Global Long-Acting Reversible Contraception(LARC) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Long-Acting Reversible Contraception(LARC) Revenue 2018-2029 (US$ Million)
Figure 15. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2018-2029)
Figure 17. Global Long-Acting Reversible Contraception(LARC) Sales 2018-2029 ((K Units)
Figure 18. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Long-Acting Reversible Contraception(LARC) Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Long-Acting Reversible Contraception(LARC) Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Long-Acting Reversible Contraception(LARC) Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Long-Acting Reversible Contraception(LARC) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Long-Acting Reversible Contraception(LARC) Sales YoY (2018-2029) & (K Units)
Figure 24. China Long-Acting Reversible Contraception(LARC) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Long-Acting Reversible Contraception(LARC) Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Long-Acting Reversible Contraception(LARC) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Long-Acting Reversible Contraception(LARC) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Long-Acting Reversible Contraception(LARC) in the World: Market Share by Long-Acting Reversible Contraception(LARC) Revenue in 2022
Figure 31. Global Long-Acting Reversible Contraception(LARC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
Figure 33. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
Figure 34. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
Figure 35. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Long-Acting Reversible Contraception(LARC) Revenue Share by Country (2018-2029)
Figure 41. US & Canada Long-Acting Reversible Contraception(LARC) Sales Share by Country (2018-2029)
Figure 42. U.S. Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
Figure 45. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
Figure 46. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
Figure 47. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
Figure 48. Europe Long-Acting Reversible Contraception(LARC) Revenue Share by Country (2018-2029)
Figure 49. Europe Long-Acting Reversible Contraception(LARC) Sales Share by Country (2018-2029)
Figure 50. Germany Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 51. France Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 55. China Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
Figure 56. China Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
Figure 57. China Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
Figure 58. China Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
Figure 59. Asia Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
Figure 60. Asia Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
Figure 61. Asia Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
Figure 62. Asia Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
Figure 63. Asia Long-Acting Reversible Contraception(LARC) Revenue Share by Region (2018-2029)
Figure 64. Asia Long-Acting Reversible Contraception(LARC) Sales Share by Region (2018-2029)
Figure 65. Japan Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 69. India Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Long-Acting Reversible Contraception(LARC) Sales Share by Country (2018-2029)
Figure 76. Brazil Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Long-Acting Reversible Contraception(LARC) Revenue (2018-2029) & (US$ Million)
Figure 81. Long-Acting Reversible Contraception(LARC) Value Chain
Figure 82. Long-Acting Reversible Contraception(LARC) Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed